These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29336668)

  • 1. Safety and biodistribution of sulfated archaeal glycolipid archaeosomes as vaccine adjuvants.
    Akache B; Stark FC; Iqbal U; Chen W; Jia Y; Krishnan L; McCluskie MJ
    Hum Vaccin Immunother; 2018 Jul; 14(7):1746-1759. PubMed ID: 29336668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulfated archaeal glycolipid archaeosomes as a safe and effective vaccine adjuvant for induction of cell-mediated immunity.
    McCluskie MJ; Deschatelets L; Krishnan L
    Hum Vaccin Immunother; 2017 Dec; 13(12):2772-2779. PubMed ID: 28537465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulfated archaeol glycolipids: Comparison with other immunological adjuvants in mice.
    Akache B; Stark FC; Jia Y; Deschatelets L; Dudani R; Harrison BA; Agbayani G; Williams D; Jamshidi MP; Krishnan L; McCluskie MJ
    PLoS One; 2018; 13(12):e0208067. PubMed ID: 30513093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic insight into the induction of cellular immune responses by encapsulated and admixed archaeosome-based vaccine formulations.
    Agbayani G; Jia Y; Akache B; Chandan V; Iqbal U; Stark FC; Deschatelets L; Lam E; Hemraz UD; Régnier S; Krishnan L; McCluskie MJ
    Hum Vaccin Immunother; 2020 Sep; 16(9):2183-2195. PubMed ID: 32755430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfated lactosyl archaeol (SLA) archaeosomes as a vaccine adjuvant.
    Akache B; McCluskie MJ
    Hum Vaccin Immunother; 2024 Dec; 20(1):2395081. PubMed ID: 39278862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro evaluation of archaeosome vehicles for transdermal vaccine delivery.
    Jia Y; McCluskie MJ; Zhang D; Monette R; Iqbal U; Moreno M; Sauvageau J; Williams D; Deschatelets L; Jakubek ZJ; Krishnan L
    J Liposome Res; 2018 Dec; 28(4):305-314. PubMed ID: 28948854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Archaeobacterial ether lipid liposomes (archaeosomes) as novel vaccine and drug delivery systems.
    Patel GB; Sprott GD
    Crit Rev Biotechnol; 1999; 19(4):317-57. PubMed ID: 10723627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Archaeosome immunostimulatory vaccine delivery system.
    Patel GB; Chen W
    Curr Drug Deliv; 2005 Oct; 2(4):407-21. PubMed ID: 16305444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of archaeosome adjuvants evaluated in a mouse model.
    Patel GB; Omri A; Deschatelets L; Sprott GD
    J Liposome Res; 2002 Nov; 12(4):353-72. PubMed ID: 12519630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the immune responses induced by antigens in three different archaeosome-based vaccine formulations.
    Jia Y; Akache B; Deschatelets L; Qian H; Dudani R; Harrison BA; Stark FC; Chandan V; Jamshidi MP; Krishnan L; McCluskie MJ
    Int J Pharm; 2019 Apr; 561():187-196. PubMed ID: 30836154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a Liposomal Vaccine Adjuvant Based on Sulfated S-Lactosylarchaeol (SLA) Glycolipids.
    Akache B; Jia Y; Chandan V; Deschatelets L; McCluskie MJ
    Methods Mol Biol; 2022; 2412():255-267. PubMed ID: 34918249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Archaeal lipid vaccine adjuvants for induction of cell-mediated immunity.
    Haq K; Jia Y; Krishnan L
    Expert Rev Vaccines; 2016 Dec; 15(12):1557-1566. PubMed ID: 27276183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulfated Lactosyl Archaeol Archaeosomes Synergize with Poly(I:C) to Enhance the Immunogenicity and Efficacy of a Synthetic Long Peptide-Based Vaccine in a Melanoma Tumor Model.
    Akache B; Agbayani G; Stark FC; Jia Y; Dudani R; Harrison BA; Deschatelets L; Chandan V; Lam E; Hemraz UD; Régnier S; Krishnan L; McCluskie MJ
    Pharmaceutics; 2021 Feb; 13(2):. PubMed ID: 33673382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Archaeosomes as self-adjuvanting delivery systems for cancer vaccines.
    Krishnan L; Dennis Sprott G;
    J Drug Target; 2003; 11(8-10):515-24. PubMed ID: 15203920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Archaeosome vaccine adjuvants induce strong humoral, cell-mediated, and memory responses: comparison to conventional liposomes and alum.
    Krishnan L; Dicaire CJ; Patel GB; Sprott GD
    Infect Immun; 2000 Jan; 68(1):54-63. PubMed ID: 10603368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of recombinant adenovirus vectors and adjuvanted protein as a heterologous prime-boost strategy using HER2 as a model antigen.
    Haq K; Jia Y; Elahi SM; MacLean S; Akache B; Gurnani K; Chattopadhyay A; Nazemi-Moghaddam N; Gilbert R; McCluskie MJ; Weeratna RD
    Vaccine; 2019 Nov; 37(47):7029-7040. PubMed ID: 31506193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Archaeosome adjuvants: immunological capabilities and mechanism(s) of action.
    Krishnan L; Sprott GD
    Vaccine; 2008 Apr; 26(17):2043-55. PubMed ID: 18343538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuning the immune response: sulfated archaeal glycolipid archaeosomes as an effective vaccine adjuvant for induction of humoral and cell-mediated immunity towards the SARS-CoV-2 Omicron variant of concern.
    Renner TM; Akache B; Stuible M; Rohani N; Cepero-Donates Y; Deschatelets L; Dudani R; Harrison BA; Baardsnes J; Koyuturk I; Hill JJ; Hemraz UD; Régnier S; Lenferink AEG; Durocher Y; McCluskie MJ
    Front Immunol; 2023; 14():1182556. PubMed ID: 37122746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Archaeosomes varying in lipid composition differ in receptor-mediated endocytosis and differentially adjuvant immune responses to entrapped antigen.
    Sprott GD; Sad S; Fleming LP; Dicaire CJ; Patel GB; Krishnan L
    Archaea; 2003 Oct; 1(3):151-64. PubMed ID: 15803661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Archaeosomes induce enhanced cytotoxic T lymphocyte responses to entrapped soluble protein in the absence of interleukin 12 and protect against tumor challenge.
    Krishnan L; Sad S; Patel GB; Sprott GD
    Cancer Res; 2003 May; 63(10):2526-34. PubMed ID: 12750276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.